Keyphrases
Attendants
9%
Blood Glucose Control
9%
Central Vision
9%
Cystoid Macular Edema
18%
Diabetes
100%
Diabetes Duration
9%
Diabetic
100%
Disease Progression
9%
Early Warning of Diseases
9%
Fovea
100%
Foveal Thickness
9%
Glycated Hemoglobin
9%
Glycemic Control
100%
Hemoglobin A1c (HbA1c)
45%
High Centre
18%
Indianapolis
9%
Intravitreal Injection
9%
Japan
9%
Macular Thickness
9%
Macular Volume
9%
Maculopathy
9%
Multiple Linear Regression Analysis
9%
Non-diabetic
54%
Preclinical Stage
9%
Swept-source Optical Coherence Tomography (SS-OCT)
100%
Tokyo
9%
Total Macular Volume
9%
Triton
9%
Tunnel Oxide Passivated Contact (TOPCon)
9%
Medicine and Dentistry
Blood Glucose Monitoring
7%
Diabetes
100%
Diabetes Mellitus
100%
Diagnosis
7%
Disease Exacerbation
7%
Glycated Hemoglobin
7%
Glycemic Control
100%
Intravitreal Administration
7%
Maculopathy
7%
Multiple Linear Regression Analysis
7%
N [bis(1 Aziridinyl)phosphinyl] 4 Iodobenzamide
7%
Optical Coherence Tomography
100%
Retina Macula Cystoid Edema
15%
Tyloxapol
7%
Vision
7%
Biochemistry, Genetics and Molecular Biology
Blood Glucose Monitoring
25%
Glycated Hemoglobin
25%
Glycemic Control
100%
Liquid
25%
Maculopathy
25%
Optics
100%
Preclinical Study
25%
Vision
25%
Nursing and Health Professions
Blood Glucose Monitoring
7%
Diabetes Mellitus
100%
Diagnosis
7%
Disease Exacerbation
7%
Glycosylated Hemoglobin
7%
Intravitreal Drug Administration
7%
Macular Thickness
7%
Multiple Linear Regression Analysis
7%
N [bis(1 Aziridinyl)phosphinyl] 4 Iodobenzamide
7%
Optical Coherence Tomography
100%
Optical Coherence Tomography Device
7%
Preclinical Study
7%
Retina Macula Cystoid Edema
15%
Retina Maculopathy
7%
Immunology and Microbiology
Glucose Blood Level
25%
Glycemic Control
100%
Liquid
25%
Optics
100%
Preclinical Study
25%
Vision
25%